{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:59:44Z","timestamp":1790711984864,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s40120-024-00668-9","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T11:02:25Z","timestamp":1730545345000},"page":"135-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Factors and Reasons Associated with Hesitating to Seek Care for Migraine: Results of the OVERCOME (US) Study"],"prefix":"10.1007","volume":"14","author":[{"given":"Robert E.","family":"Shapiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7929-3704","authenticated-orcid":false,"given":"Eva Jolanda","family":"Muenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Zagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"L.\u00a0Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn C.","family":"Buse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sait","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Pearlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,2]]},"reference":[{"issue":"10283","key":"668_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, \u00d6zge A, et al. Migraine: epidemiology and systems of care. Lancet. 2021;397(10283):1485\u201395.","journal-title":"Lancet"},{"key":"668_CR2","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/head.13407","volume":"58","author":"RB Lipton","year":"2018","unstructured":"Lipton RB, Munjal S, Alam A, Buse DC, Fanning KM, Reed ML, et al. Migraine in America Symptoms and Treatment (MAST) Study: Baseline study methods, treatment patterns, and gender differences. Headache. 2018;58:1408\u201326.","journal-title":"Headache"},{"key":"668_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/head.12774","volume":"56","author":"DW Dodick","year":"2016","unstructured":"Dodick DW, Loder EW, Manack Adams A, Buse DC, Fanning KM, et al. Assessing barriers to chronic migraine consultation, diagnosis, and treatment: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study. Headache. 2016;56:821\u201334.","journal-title":"Headache"},{"key":"668_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1526-4610.2012.02265.x","volume":"53","author":"RB Lipton","year":"2013","unstructured":"Lipton RB, Serrano D, Holland S, Fanning KM, Reed ML, Buse DC. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features. Headache. 2013;53:81\u201392.","journal-title":"Headache"},{"issue":"62","key":"668_CR5","first-page":"1","volume":"2022","author":"Cohen F, Brooks CV, Sun DM, Reed ML, Buse DC, Lipton RB. Migraine prevalence has remained stable while disability has increased in US population studies. Paper presented at: American Headache Society 64th Annual Scientific Meeting; June 9\u201312","year":"2022","unstructured":"Cohen F, Brooks CV, Sun DM, Reed ML, Buse DC, Lipton RB. Migraine prevalence has remained stable while disability has increased in US population studies. Paper presented at: American Headache Society 64th Annual Scientific Meeting; June 9\u201312. Denver, CO. Headache. 2022;2022(62):1\u2013170.","journal-title":"Headache"},{"key":"668_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/head.14259","volume":"62","author":"RB Lipton","year":"2022","unstructured":"Lipton RB, Nicholson RA, Reed ML, Araujo AB, Jaffe DH, Faries DE, et al. Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study. Headache. 2022;62:122\u201340.","journal-title":"Headache"},{"issue":"18 Supplement","key":"668_CR7","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1212\/WNL.98.18_supplement.3114","volume":"98","author":"S Ashina","year":"2022","unstructured":"Ashina S, Muenzel EJ, Nicholson RA, Zagar AJ, Buse DC, Reed ML, et al. Factors associated with seeking care for migraine: Results of the OVERCOME (US) study. Neurology. 2022;98(18 Supplement):3114.","journal-title":"Neurology"},{"key":"668_CR8","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/head.12553","volume":"55","author":"D Serrano","year":"2015","unstructured":"Serrano D, Buse DC, Manack Adams A, Reed ML, Lipton RB. Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2015;55:502\u201318.","journal-title":"Headache"},{"key":"668_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders. 3rd ed. Cephalalgia. 2018;38:1\u2013211.","journal-title":"Cephalalgia"},{"key":"668_CR10","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/head.14401","volume":"62","author":"EK Seng","year":"2022","unstructured":"Seng EK, Shapiro RE, Buse DC, Robbins MS, Lipton RB, Parker A. The unique role of stigma in migraine-related disability and quality of life. Headache. 2022;62:1354\u201364.","journal-title":"Headache"},{"issue":"3","key":"668_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208074","volume":"102","author":"RE Shapiro","year":"2024","unstructured":"Shapiro RE, Nicholson RA, Seng EK, Buse DC, Reed ML, Zagar AJ, et al. Migraine-related stigma and its relationship to disability, interictal burden, and quality of life: Results of the OVERCOME (US) study. Neurology. 2024;102(3): e208074.","journal-title":"Neurology"},{"key":"668_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1526-4610.2001.01156.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2001;41:854\u201361.","journal-title":"Headache"},{"issue":"6 Suppl 1","key":"668_CR13","first-page":"S20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20\u20138.","journal-title":"Neurology"},{"key":"668_CR14","first-page":"778","volume":"47","author":"DC Buse","year":"2007","unstructured":"Buse DC, Bigal M, Rupnow M, Reed M, Serrano D, Biondi D, et al. The Migraine Interictal Burden Scale (MIBS): Results of a population-based validation study. Headache. 2007;47:778.","journal-title":"Headache"},{"key":"668_CR15","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0025-6196(11)60561-2","volume":"84","author":"DC Buse","year":"2009","unstructured":"Buse DC, Rupnow MFT, Lipton RB. Assessing and managing all aspects of migraine: Migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc. 2009;84:422\u201335.","journal-title":"Mayo Clin Proc"},{"key":"668_CR16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s11136-012-0230-7","volume":"22","author":"R Rendas-Baum","year":"2003","unstructured":"Rendas-Baum R, Bloudek LM, Maglinte GA, Varon SF. The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients. Qual Life Res. 2003;22:1123\u201333.","journal-title":"Qual Life Res"},{"key":"668_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2165\/00019053-199813060-00007","volume":"13","author":"P Jhingran","year":"1998","unstructured":"Jhingran P, Davis SM, LaVange LM, Miller DW, Helms RW. MSQ: migraine-specific quality-of-life questionnaire. Further investigation of the factor structure. Pharmacoeconomics. 1998;13:707\u201317.","journal-title":"Pharmacoeconomics"},{"key":"668_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1526-4610.1998.3804295.x","volume":"38","author":"P Jhingran","year":"1998","unstructured":"Jhingran P, Osterhaus JT, Miller DW, Lee JT, Kirchdoerfer L. Development and validation of the Migraine-Specific Quality of Life Questionnaire. Headache. 1998;38:295\u2013302.","journal-title":"Headache"},{"key":"668_CR19","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s11136-007-9217-1","volume":"16","author":"JC Cole","year":"2007","unstructured":"Cole JC, Lin P, Rupnow MF. Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 21.) for patients undergoing prophylactic migraine treatment. Qual Life Res. 2007;16:1231\u20137.","journal-title":"Qual Life Res"},{"key":"668_CR20","first-page":"S40","volume":"50","author":"D Serrano","year":"2010","unstructured":"Serrano D, Buse D, Reed M, Runken M, Lipton R. Development of the Migraine Symptom Severity Score (MSSS): A latent variable model for migraine definition. Headache. 2010;50:S40.","journal-title":"Headache"},{"key":"668_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ana.21211","volume":"63","author":"RB Lipton","year":"2008","unstructured":"Lipton RB, Bigal ME, Ashina S, Burstein R, Silberstein S, Reed ML, et al. Cutaneous allodynia in the migraine population. Ann Neurol. 2008;63:148\u201358.","journal-title":"Ann Neurol"},{"key":"668_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2009.06.019","volume":"122","author":"B L\u00f6we","year":"2010","unstructured":"L\u00f6we B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122:86\u201395.","journal-title":"J Affect Disord"},{"key":"668_CR23","doi-asserted-by":"publisher","first-page":"7625","DOI":"10.3390\/ijerph18147625","volume":"18","author":"H Byeon","year":"2021","unstructured":"Byeon H. Exploring factors for predicting anxiety disorders of the elderly living alone in South Korea using interpretable machine learning: A population-based study. Int J Environ Res Public Health. 2021;18:7625.","journal-title":"Int J Environ Res Public Health"},{"key":"668_CR24","doi-asserted-by":"publisher","DOI":"10.2196\/27344","volume":"23","author":"SM Nam","year":"2021","unstructured":"Nam SM, Peterson TA, Seo KY, Han HW, Kang JI. Discovery of depression-associated factors from a nationwide population-based survey: Epidemiological study using machine learning and network analysis. J Med Internet Res. 2021;23: e27344.","journal-title":"J Med Internet Res"},{"key":"668_CR25","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.jad.2021.09.018","volume":"295","author":"CL van Vuuren","year":"2021","unstructured":"van Vuuren CL, van Mens K, de Beurs D, Lokkerbol J, van der Wal MF, Cuijpers P, et al. Comparing machine learning to a rule-based approach for predicting suicidal behavior among adolescents: Results from a longitudinal population-based survey. J Affect Disord. 2021;295:1415\u201320.","journal-title":"J Affect Disord"},{"key":"668_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45:5\u201332.","journal-title":"Mach Learn"},{"key":"668_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"2001","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Ser B (Methodological). 2001;58:267\u201388.","journal-title":"J R Stat Soc Ser B (Methodological)"},{"key":"668_CR28","unstructured":"Breiman L, Cutler A. Manual\u2013setting up, using, and understanding random forests V4.0. 2003. https:\/\/www.stat.berkeley.edu\/~breiman\/Using_random_forests_v4.0.pdf."},{"key":"668_CR29","unstructured":"Inc. SI. The HPFOREST Procedure: Loss Reduction. 2020. https:\/\/documentation.sas.com\/doc\/en\/emhpprcref\/14.2\/emhpprcref_hpforest_examples04.htm."},{"key":"668_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s10194-016-0599-8","volume":"17","author":"C Lampl","year":"2016","unstructured":"Lampl C, Thomas H, Stovner LJ, Tassorelli C, Katsarava Z, La\u00ednez JM, et al. Interictal burden attributable to episodic headache: findings from the Eurolight project. J Headache Pain. 2016;17:9.","journal-title":"J Headache Pain"},{"key":"668_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/oxfordhb\/9780190243470.013.19","volume-title":"The Oxford handbook of stigma, discrimination, and health","author":"DM Quinn","year":"2017","unstructured":"Quinn DM. When stigma is concealable: The costs and benefits for health. In: Major B, Dovidio JF, Link BG, editors. The Oxford handbook of stigma, discrimination, and health. New York, NY: Oxford University Press; 2017. p. 287\u201399."},{"issue":"1","key":"668_CR32","first-page":"e22","volume":"4","author":"J Cudjoe","year":"2020","unstructured":"Cudjoe J, Delva S, Cajita M, Han HR. Empirically tested health literacy frameworks. Health Lit Res Pract. 2020;4(1):e22\u201344.","journal-title":"Health Lit Res Pract"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-024-00668-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-024-00668-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-024-00668-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T16:18:39Z","timestamp":1737821919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-024-00668-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["668"],"URL":"https:\/\/doi.org\/10.1007\/s40120-024-00668-9","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,2]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Robert E. Shapiro: Consulting: Eli Lilly and Company, Lundbeck, AbbVie\/Allergan, Theranica. Michael L. Reed: Consulting, Research Grants: AbbVie\/Allergan, Amgen, Eli Lilly and Company, GlaxoSmithKline, National Headache Foundation, Promius. Dawn C. Buse: Consulting, Honoraria, Research Grants: AbbVie\/Allergan, Amgen, Biohaven, Collegium, Eli Lilly and Company, Teva. Susan Hutchinson: Consulting, Speaking, Honoraria: AbbVie\/Allergan, Amgen, Biohaven, Currax, electroCore, Eli Lilly and Company, Impel, Lundbeck, Teva, Theranica, Upsher-Smith. Sait Ashina: Consulting, Teaching, Honoraria: AbbVie\/Allergan, Biohaven Pharmaceuticals, Eli Lilly and Company, Impel NeuroPharma, Lundbeck, Satsuma, Percept, Teva, Theranica; Consulting and Advisory Board: Pfizer. Richard B. Lipton: Stock or options: Manistee Health; Consultant, Advisory Board Member, Honoraria from or research support: Abbvie (Allergan), American Academy of Neurology, American Headache Society, Aeon, Amgen, Biohaven, Biovision, Boston, Dr. Reddy\u2019s (Promius), electroCore, Eli Lilly and Company, Equinox, GlaxoSmithKline, Grifols, Lundbeck, Merck, Pernix, Pfizer, Teva, Vector, Vedanta. E. Jolanda Muenzel, Robert A. Nicholson, Anthony J. Zagar, and Eric M. Pearlman: Employee\/Shareholder: Eli Lilly and Company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The Sterling Institutional Review Board (IRB ID #6425\u2013001) provided approval for this non-interventional, observational survey study. All respondents provided electronic informed consent to participate in a general health-related survey. This was a non-interventional, observational study and not registered with a clinical trials registry.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}